[HTML][HTML] Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats

D Gao, N Ning, G Hao, X Niu - PPAR research, 2012 - hindawi.com
Objective. We sought to investigate whether the peroxisome proliferator-activated receptor-γ
(PPAR-γ) ligand pioglitazone can attenuate vascular fibrosis in spontaneously hypertensive …

Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases

W San Cheang, X Fang, XY Tian - Circulation Journal, 2013 - jstage.jst.go.jp
2665 PPARγ, PPARδ and Vascular Diseases inhibits the response of VSMC to inflammatory
stimuli. Tumor necrosis factor alpha (TNFα)-induced expression of chemokines VCAM-1 …

Effect of peroxisome proliferator–activated receptor-α and-γ activators on vascular remodeling in endothelin-dependent hypertension

M Iglarz, RM Touyz, F Amiri, MF Lavoie… - … , and vascular biology, 2003 - Am Heart Assoc
Objective—Peroxisome proliferator–activated receptors (PPARs) may modulate in vitro the
vascular production of vasoactive peptides such as endothelin-1 (ET-1). Thus, we …

Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering …

A Martin, JV Perez-Giron, R Hernanz… - Journal of …, 2012 - journals.lww.com
Aims: Hypertension is associated with increased plasma inflammatory markers such as
cytokines and increased vascular cyclooxygenase-2 (COX-2) expression. The ability of …

A potent activator of PPARα and γ reduces the vascular cell recruitment and inhibits the intimal thickning in hypercholesterolemic rabbits

N Seki, H Bujo, M Jiang, M Shibasaki, K Takahashi… - Atherosclerosis, 2005 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) regulate the vascular cell functions as
well as systemic lipid and glucose metabolism. Here, we studied the effect of TAK-559, a …

Newly developed PPAR-α agonist (R)-K-13675 inhibits the secretion of inflammatory markers without affecting cell proliferation or tube formation

K Kitajima, S Miura, Y Mastuo, Y Uehara, K Saku - Atherosclerosis, 2009 - Elsevier
Peroxisome proliferator-activated receptor-alpha (PPAR-α) is a key regulator of lipid and
glucose metabolism and has been implicated in inflammation. The vascular effects of …

Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation

KY Kim, JH Ahn, HG Cheon - Molecular and cellular biochemistry, 2011 - Springer
Peroxisome proliferator-activated receptor γ (PPARγ) activation has anti-angiogenic and
apoptotic effects in endothelial cells. Here, we investigated the mechanisms of the anti …

Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

MJ Zarzuelo, R Jiménez, P Galindo, M Sánchez… - …, 2011 - Am Heart Assoc
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor β/δ
(PPARβ) has been shown to improve insulin resistance and plasma high-density lipoprotein …

Peroxisome proliferator-activated receptors and the vascular system: beyond their metabolic effects

C Marchesi, EL Schiffrin - Journal of the American Society of Hypertension, 2008 - Elsevier
Peroxisome proliferator-activated receptors (PPARs) alpha and gamma are ligand-activated
transcription factors belonging to the nuclear receptor superfamily. PPARα has effects on …

[HTML][HTML] PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats

Z Yousefipour, M Newaz - Acta Pharmacologica Sinica, 2014 - nature.com
Aim: Peroxisome proliferator activated receptors (PPARs) are nuclear transcription factors
that regulate numerous genes influencing blood pressure. The aim of this study was to …